Related Experiment Videos
Inappropriate medications and older people: has anything changed over time?
1Pharmacy Practice, School of Pharmacy, Texas Tech University, Health Sciences Center, Amarillo, TX, USA. carlos.rojas-fernandez@bms.com
The Annals of Pharmacotherapy
|July 5, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Assessment of Oral Anticoagulant Use in Residents of Long-Term Care Homes: Evidence for Contemporary Suboptimal Use.
The Annals of pharmacotherapy·2017
A scoping review on medication adherence in older patients with cognitive impairment or dementia.
Research in social & administrative pharmacy : RSAP·2016
Use of ultra-low-dose (≤6 mg) doxepin for treatment of insomnia in older people.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2014
The legibility of prescription medication labelling in Canada: Moving from pharmacy-centred to patient-centred labels.
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC·2014
Impact of Duration of Intravenous Octreotide Infusion on Achieving Hemostasis in Patients With Acute Variceal Hemorrhage.
The Annals of pharmacotherapy·2026
Prediction of Early Heparin Response in Patients With Venous Thromboembolism.
The Annals of pharmacotherapy·2026
Pharmacologic Strategies for Anemia in Patient Blood Management: A Systematic Review and Practical Clinical Synthesis.
The Annals of pharmacotherapy·2026
Efficacy and Safety of Levetiracetam Versus Sodium Valproate in Pediatric Epilepsy: A Systematic Review and Meta-analysis.
The Annals of pharmacotherapy·2026
Buprenorphine Dispensed by Pharmacies and Administered in Emergency Departments in Urban and Rural Areas - United States, 2019-2025.
MMWR. Morbidity and mortality weekly report·2026
Rheumatoid Arthritis Guidelines Require Dietary Recommendations: An Overlooked Opportunity.
Clinical nutrition ESPEN·2026
Assessment of the impact of valproic acid co-administration on clozapine plasma concentrations in Tunisian patients.
Drug metabolism and personalized therapy·2026
Benefit-Risk of Voxelotor, Crizanlizumab, and L-Glutamine in Sickle Cell Disease: A Systematic Review.
The American journal of the medical sciences·2026